Viking Therapeutics stock soared 21% in early trade Monday after the biotech posted data on its oral weight-loss drug showing better-than-expected results from a Phase 1 trial. The study of VK2735 amo ...
Do you want to improve your health and lose weight? It may be cheaper than you think to buy health and fitness products. Find ...
The Ultimate Fighting Championship's return to Alberta, Canada, is now official after the UFC Fight Night 246 weigh-ins.
Type 2 diabetes drug Mounjaro and weight-loss drug Zepbound remained the brightest stars in Lilly's lineup. Mounjaro's sales more than doubled year over year to $3.1 billion. Sales for Zepbound, which ...
Eli Lilly had a bad quarter, with sales of GLP-1 drugs Mounjaro and Zepbound missing analyst estimates. The disappointment led to a [15% plunge in Lilly’s shares]( ...
The S&P 500 and Nasdaq are slightly higher. The Dow was lower Tuesday as the stock market braces for a big day of earnings.